General Archives - Korecyte Bio

Home
About us
- Management
- Advisors
Our science
- Technology
- Pipeline
Careers
- Latest vacancies
Partners & Investors
- Partners
- Investors
News
- Latest news
Contact us
- General enquiries
- Business development

Radboud University Master’s students drafted a growth plan

Korecyte presented at LSX Investival Showcase 2024

Korecyte presented at CRL’s European CGT Summit 2024

Korecyte receives Innovate UK grant

Korecyte pitch at Medcity Investment Hub

Korecyte Innovations Ltd. incorporated at LBIC London

Korecyte presented at the Global Investor Forum in Rotterdam

Korecyte presented at the CAR-TCR Summit 2024 in London

Korecyte presented at the Dutch Life Sciences Conference Leiden

Korecyte attending LSN-RESI Boston conference 2023

1 2 Next

Site navigation

Home
Management
Technology
Pipeline
Vacancies
Partners and Investors
News
Contact us
Privacy policy
Cookie statement

Location

Korecyte Bio Ltd.
33 Cavendish Square
London W1G 0PW
United Kingdom

About Korecyte Bio

We understand the hardships that cancer patients and their loved ones face, which is why we are committed to developing the next-generation CAR-T therapy that is safe and effective for treating solid tumours. Join us in our mission to eradicate cancer and provide hope to millions of patients worldwide.

Contact details

General inquiries: info@korecyte.com.

In case you have a collaboration project to discuss, reach out to business development at: BD@korecyte.com.

X

LinkedIn

This website uses cookies to ensure that you have the best experience. If you continue to use this site we will assume that you agree to this.